Literature DB >> 19371978

Mono and bis-6-arylbenzimidazo[1,2-c]quinazolines: a new class of antimicrobial agents.

Rondla Rohini1, Kanne Shanker, Puchakayala Muralidhar Reddy, Yen-Peng Ho, Vadde Ravinder.   

Abstract

With the aim of obtaining novel biologically active compounds, we have synthesized a series of mono, bis-2-o-arylideneaminophenylbenzimidazoles and a second series of corresponding mono, bis-6-arylbenzimidazo[1,2-c]quinazolines respectively. The target benzimidazo[1,2-c]quinazoline compounds were obtained by the condensation of 2-(o-aminophenyl)benzimidazole with mono and di carbonyl compounds, followed by oxidative cyclisation of the resulting mono and bis-2-o-arylideneaminophenylbenzimidazoles.All the products were characterized via IR, (1)H NMR, (13)C NMR, MS and elemental analysis. The antimicrobial activities of all quinazolines against various bacteria and fungi were evaluated. Among the compounds tested IVd, IVe exhibited good antibacterial and antifungal activities while IIIb, IIIc also showed notable antimicrobial activity with reference to standard drugs Ampicillin and Ketoconazole respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371978     DOI: 10.1016/j.ejmech.2009.03.022

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Solvent-free synthesis of isoindolo[2,1-c]pyrazolo[1,5-a]quinazoline and pyrazolo[5',1':2,3]pyrimido[6,1-a]isoindol derivatives through a one-pot three-component reaction.

Authors:  Meysam Alizadeh-Kouzehrash; Abbas Rahmati
Journal:  Mol Divers       Date:  2020-02-19       Impact factor: 2.943

2.  {2,6-Bis[(4-bromo-phen-yl)imino-meth-yl]pyridine-κN,N',N''}trichlorido-chromium(III).

Authors:  Xiao-Ping Li; Yong-Yong Liu; Jian-She Zhao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-08

3.  In-silico docking based design and synthesis of [1H,3H] imidazo[4,5-b] pyridines as lumazine synthase inhibitors for their effective antimicrobial activity.

Authors:  Sunil L Harer; Manish S Bhatia
Journal:  J Pharm Bioallied Sci       Date:  2014-10

4.  Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against Plasmodium falciparum, Human Cytomegalovirus, and Leukemia Cells.

Authors:  Tony Fröhlich; Christoph Reiter; Mohammad M Ibrahim; Jannis Beutel; Corina Hutterer; Isabel Zeitträger; Hanife Bahsi; Maria Leidenberger; Oliver Friedrich; Barbara Kappes; Thomas Efferth; Manfred Marschall; Svetlana B Tsogoeva
Journal:  ACS Omega       Date:  2017-06-01

5.  Microwave synthesis, crystal structure, antioxidant, and antimicrobial study of new 6-heptyl-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline compound.

Authors:  Hiba Ali Hasan; Emilia Abdulmalek; Mohd Basyaruddin Abdul Rahman; Khozirah Binti Shaari; Bohari Mohd Yamin; Kim Wei Chan
Journal:  Chem Cent J       Date:  2018-12-20       Impact factor: 4.215

6.  Synthesis of N-Fused Benzimidazole-4,7-diones via Sequential Copper-Catalyzed C-N Coupling/Cyclization and Oxidation.

Authors:  Pham Duy Quang Dao; Son Long Ho; Chan Sik Cho
Journal:  ACS Omega       Date:  2018-05-25

7.  Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.

Authors:  Krishnan Suresh Kumar; Swastika Ganguly; Ravichandran Veerasamy; Erik De Clercq
Journal:  Eur J Med Chem       Date:  2010-08-06       Impact factor: 6.514

8.  Quinazoline derivatives: synthesis and bioactivities.

Authors:  Dan Wang; Feng Gao
Journal:  Chem Cent J       Date:  2013-06-03       Impact factor: 4.215

9.  2-(4-Bromo-phen-yl)-N-[3-(1H-imidazol-1-yl)prop-yl]quinazolin-4-amine.

Authors:  Marcia Pérez-Fehrmann; Victor Kesternich; Felipe Verdugo; Philippe Christen; Céline Besnard
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-30

10.  A concise and efficient synthesis of benzimidazo[1,2-c]quinazolines through CuI-catalyzed intramolecular N-arylations.

Authors:  Xinlong Pang; Chao Chen; Ming Li; Chanjuan Xi
Journal:  Beilstein J Org Chem       Date:  2015-11-30       Impact factor: 2.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.